| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |